Joint Bone Spine
Joint Bone Spine is a bimonthly, electronic-only international journal published by Elsevier Masson and the official organ of the French Society of Rheumatology, devoted to disorders of the joints, bones and spine, with a 2025 Journal Impact Factor of 5.0.《关节骨脊柱》(Joint Bone Spine)由(Elsevier Masson)出版,是法国风湿病学会的会刊,双月刊、仅电子版,聚焦关节、骨骼与脊柱疾病,2025 年期刊影响因子为 5.0。
Scope
- The journal publishes original research articles and the latest advances on disorders affecting the joints, bones and spine.刊物发表关于关节、骨骼与脊柱疾病的原创研究论文与最新进展。
- More generally, its field is the whole of rheumatology and rheumatic diseases.更广泛地说,其领域涵盖整个风湿病学与风湿性疾病。
- Article types include original articles, editorials, general reviews, clinical cases and letters to the editor.文章类型包括原创论文、社论、综述、临床病例与读者来信。
- Surgical techniques and work focused specifically on orthopaedic surgery are explicitly outside the journal's scope.外科技术以及专门针对骨科手术的研究,被明确排除在刊物范围之外。
- Priority is given to medical and basic science studies pertinent to clinical rheumatology.刊物优先考虑与临床风湿病学相关的医学与基础科学研究。
- The journal is indexed in the main international databases and is accessible worldwide through the publisher's platforms.刊物被主要国际数据库收录,并经出版方平台向全球开放阅读。
History
- Joint Bone Spine is the international English-language continuation of Revue du Rhumatisme, the French rheumatology journal.《关节骨脊柱》是法国风湿病学期刊《风湿病学评论》(Revue du Rhumatisme)的国际英文续刊。
- An English edition of the French journal was published from 1993, before the title was relaunched as Joint Bone Spine in 2000.该法国期刊的英文版自 1993 年起出版,2000 年正式以《关节骨脊柱》这一刊名重新推出。
- The journal is the official organ of the French Society of Rheumatology and is published by Elsevier Masson in Paris.刊物为法国风湿病学会的会刊,由位于巴黎的(Elsevier Masson)出版。
- It became an electronic-only publication while keeping a bimonthly schedule of six issues a year, in January, March, May, July, October and December.刊物转为仅电子出版,同时保持每年 6 期的双月刊节奏,分别在一月、三月、五月、七月、十月与十二月出刊。
- Its 2025 Journal Impact Factor is 5.0, after 4.3 in 2024, 5.263 in 2022 and 4.929 in 2021, and it ranks in the first quartile of rheumatology.2025 年期刊影响因子为 5.0,此前 2024 年为 4.3,2022 年为 5.263,2021 年为 4.929,在风湿病学类别中位列一区。
- The journal is indexed in Science Citation Index Expanded, Embase, PubMed and MEDLINE, and Scopus.刊物被科学引文索引扩展版、Embase、PubMed 与 MEDLINE 以及 Scopus 收录。
Editors
- The Editor-in-Chief is Marie-Christophe Boissier, professor of rheumatology at Sorbonne Paris Nord and head of the rheumatology department at Avicenne Hospital in Bobigny.主编为(Marie-Christophe Boissier),巴黎北索邦大学风湿病学教授、博比尼阿维森纳医院风湿科主任。
- The editor team includes Beatrice Bouvard in Angers, Laure Gossec in Paris, Benoit Le Goff in Nantes and Frederic Liote in Paris.编辑团队包括昂热的(Beatrice Bouvard)、巴黎的(Laure Gossec)、南特的(Benoit Le Goff)与巴黎的(Frederic Liote)。
- Clement Prati in Besancon, Adeline Ruyssen-Witrand in Toulouse, Luca Semerano in Bobigny and Daniel Wendling in Besancon complete the team.贝桑松的(Clement Prati)、图卢兹的(Adeline Ruyssen-Witrand)、博比尼的(Luca Semerano)与贝桑松的(Daniel Wendling)构成团队其余成员。
- All submitted manuscripts are subjected to rigorous peer review by international experts, and publication is never guaranteed before the editorial board decides.所有来稿均经国际专家严格同行评审,在编委会作出最终决定之前,刊物不保证任何稿件得以发表。
- The journal specifies that surgical technique papers are not handled, directing such work elsewhere.刊物明确不受理外科技术类论文,将此类工作引向其他期刊。
- Content is oriented to rheumatologists, orthopaedic surgeons and physicians in physical medicine and rehabilitation.读者对象为风湿病科医师、骨科医师以及物理医学与康复科医师。